bibliographic resource 2024939 [br/2024939]
https://w3id.org/oc/corpus/br/2024939

is a
title
  • Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
publication date
  • 2016-01-01
citation
contributor
format
identifier
part of
reference